Drug Shortage Report for TEVA-SALBUTAMOL HFA

Last updated on 2020-07-30 History
Report ID 105599
Drug Identification Number 02326450
Brand name TEVA-SALBUTAMOL HFA
Common or Proper name SALBUTAMOL 100MCG HFA INHALER
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SALBUTAMOL
Strength(s) 100MCG
Dosage form(s) METERED-DOSE AEROSOL
Route of administration INHALATION
Packaging size 200 dose
ATC code R03AC
ATC description ADRENERGICS, INHALANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-02-07
Estimated end date 2020-07-31
Actual end date 2020-07-29
Shortage status Resolved
Updated date 2020-07-30
Company comments Teva Allocating to 70% of the generic market. Increased demand experienced.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-02-07 English Compare

Showing 21 to 21 of 21